Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA priority review
Biotech
Vertex meets own cystic fibrosis record with next-gen treatment
Set the bar and then beat it; that's what Vertex Pharmaceuticals has just done with a next-gen cystic fibrosis treatment.
Gabrielle Masson
Feb 5, 2024 7:50pm
FDA gives Madrigal's NASH drug priority review, no AdComm
Sep 13, 2023 10:50am
Biogen's tight-lipped zuranolone remarks disquiet Sage investors
Jul 26, 2023 10:45am
Pfizer's maternal RSV vaccine filing sets up AZ, Sanofi showdown
Feb 21, 2023 9:15am
Pfizer's RSV vaccine rush gets FDA boost with priority review
Dec 7, 2022 10:10am
FDA grants priority review to Amgen-AstraZeneca asthma drug
Jul 8, 2021 7:15am